Is Pentixapharm Holding AG halal to invest in?

According to Musaffa's Shariah screening methodology, Pentixapharm Holding AG (PTP.DE) is currently classified as NOT HALAL as of January 2026. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Pentixapharm Holding AG a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Pentixapharm Holding AG using these criteria to determine its compliance status.

Can Muslims buy shares of Pentixapharm Holding AG?

Muslim investors may consider investing in Pentixapharm Holding AG if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Pentixapharm Holding AG classified as NOT HALAL?

Musaffa determines the Shariah status of Pentixapharm Holding AG by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Pentixapharm Holding AG updated?

The Shariah compliance status of Pentixapharm Holding AG may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Pentixapharm Holding AG become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Pentixapharm Holding AG?

You can check the latest Shariah compliance status of Pentixapharm Holding AG on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

Pentixapharm Holding AG PTP.DE

€2.09

Last Updated: May 15, 12:00 AM·XETRA

PTP.DE Shariah Compliance

Screening Methodology: AAOIFI

NOT HALAL

Last Updated: January 20, 2026

Report Source: 2025 3rd Quarter Report

Analyst's Ratings for Pentixapharm Holding AG (PTP.DE)

Based on 5 analysts giving stock ratings to Pentixapharm Holding AG in the past 3 months

Strong
SellSellHoldBuyStrong
Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Pentixapharm Holding AG. Stock Analysis PTP.DE

Germany Health Care Micro Cap Report: Q3, 2025

Pentixapharm Holding AG engages in the development of radiopharmaceutical approaches for diagnostic and therapeutic programs in a number of hematological and solid cancers, as well as cardiovascular, endocrine, and inflammatory diseases. The company is headquartered in Berlin, Berlin and currently employs 61 full-time employees. The company went IPO on 2024-10-03. The firm focuses on the development of radiopharmaceuticals for various therapeutic areas, as well as for the diagnosis and therapy (theranostics) of blood cancer and others. The company is also engaged in holding activities and is also involved in the research and development of drugs for hematological and solid cancers, as well as cardiovascular, endocrine and inflammatory diseases.

Key Statistics of Pentixapharm Holding AG (PTP.DE)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

€2.09€2.20

Today's Open

€2.09

Volume

796.00

P/E Ratio (TTM)

52 Week Range

€1.30€3.70

Market Cap

52.29M

Avg. Volume

1751.00

Dividend Yield

Financial Metrics & Statements of Pentixapharm Holding AG (PTP.DE)

FAQ's for Pentixapharm Holding AG (PTP.DE)

According to Musaffa’s Shariah screening methodology, Pentixapharm Holding AG (PTP.DE) is currently classified as NOT HALAL as of January 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.